2009 Press Kits
New Guideline: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders
A new guideline issued by the American Academy of Neurology finds that transcutaneous electric nerve stimulation (TENS), a widely used pain therapy involving a portable device, is not recommended to treat chronic low-back pain—pain that has persisted for three months or longer—because research shows it is not effective. The guideline is published in the December 30, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The guideline determined that TENS can be effective in treating diabetic nerve pain, also called diabetic neuropathy, but more and better research is needed to compare TENS to other treatments for this type of pain.
- Guideline
- Clinician Summary
- Q&A: Richard M. Dubinsky Discusses New Guideline on the Efficacy of TENS for Treatment of Pain
- Editorial
- Press Release
Neuro Film Festival
People who have compelling stories to share regarding how they or a loved one has been affected by a brain disorder are invited to submit a short video to the 2010 Neuro Film Festival, an AAN Foundation event that aims to raise awareness about brain disorders and the need to support research into preventions, treatments and cures. The deadline to enter is February 16, 2010.
- Press Release
- NeuroFilmFestival.com
- Neuro Film Festival YouTube Channel
- Neuro Film Festival Facebook Page
- Neuro Film Festival Poster
New Guidelines: The care of the patient with amyotrophic lateral sclerosis (ALS)
New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease.
- Guildelines
- Clinician Summaries
- Q&A: Robert G. Miller Discusses New ALS Guidelines
- Patient Summaries
- Press Release
- Public Service Announcements
- 60 Seconds (.mp3)
- 30 Seconds (.mp3)
- 20 Seconds (.mp3)
- 10 Seconds (.mp3)
New Guideline: Evaluation of the Child with Microcephaly
A new guideline from the American Academy of Neurology, developed in full collaboration with the Child Neurology Society, finds that children with microcephaly—that is, children whose head size is smaller than that of 97 percent of children—are at risk of neurologic and cognitive problems and should be screened for these problems.
- Practice Parameter: Evaluation of the child with microcephaly (an evidence-based review)
- Clinician Summary
- Microcephaly Q&A
- Patient Summary
- Press Release
AAN Collaborates with CDC on H1N1 Vaccine Safety Monitoring
The Centers for Disease Control and Prevention (CDC) and the American Academy of Neurology (AAN) are requesting neurologists to report any possible new cases of Guillain-Barré syndrome (GBS) following 2009 H1N1 flu vaccination using the CDC and US Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS).
New Guidelines: Management Issues for Women with Epilepsy
New guidelines developed by the American Academy of Neurology and the American Epilepsy Society show relative safety for women with epilepsy to become pregnant, but caution must be taken, including avoiding one particular epilepsy drug that can cause birth defects.
- Guidelines
- Vitamin K, folic acid, blood levels, and breastfeeding
- Obstetrical complications and change in seizure frequency
- Teratogenesis and perinatal outcomes
- Patient and Clinician Summaries
- Press Release
- Press Briefing at the Annual Meeting
- Q&A: Cynthia Harden Discusses New Guidelines
- Public Service Announcements
- 60 Seconds (.mp3)
- 30 Seconds (.mp3)
- 20 Seconds (.mp3)
- 15 Seconds (.mp3)
Video: AAN Parkinson's Disease Patient Education
- Parkinson's Disease: A Guide for Patients & Families (AAN YouTube channel)
- Parkinson's Disease: A Guide for Patients & Families—Part 1 of 3 (video)